Stocks & Financial News
Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts
HLS Therapeutics partners with Esperion Therapeutics to commercialize NEXLETOL® and NEXLIZET® in Canada
TORONTO, May 8, 2025 (CNW Group via COMTEX) --
SOURCE HLS Therapeutics Inc.
SOURCE: HLS Therapeutics Inc.
HLS CONTACT INFORMATION: Dave Mason, Investor Relations, HLS Therapeutics Inc., (416) 247-9652, d.mason@hlstherapeutics.com
COMTEX_465320736/2197/2025-05-08T06:30:00